[1. Epilepsy in the WHO European Region: Fostering Epilepsy Care in Europe 2010. http://www.ibe-epilepsy.org/downloads/EURO%20 Report%20160510.pdf]Search in Google Scholar
[2. Malmgren K, Flink R, Guekht AB, et al. ILAE Commission of European Affairs Subcommission on European Guidelines 1998-2001: The provision of epilepsy care across Europe. Epilepsia. 2003; 44(5): 727-731.10.1046/j.1528-1157.2003.58402.x]Search in Google Scholar
[3. Wiebe S, Tellez-Zenteno J, Shapiro M. An evidencebased approach to the first seizure Epilepsia. 2008; 49 (Suppl. 1): 50-57.10.1111/j.1528-1167.2008.01451.x]Search in Google Scholar
[4. Marson A. When to start antiepileptic drug treatment and with what evidence? Epilepsia. 2008; 49 (Suppl. 1): 3-6.10.1111/j.1528-1167.2008.01920.x]Search in Google Scholar
[5. Perucca E, Tomson T. The pharmacological treatment of epilepsy in adults. Lancet Neurol. 2011; 10: 446-56.10.1016/S1474-4422(11)70047-3]Search in Google Scholar
[6. Hixson J. Stopping Antiepileptic Drugs: When and Why? Current Treatment Options in Neurology. 2010; 12: 434-442.]Search in Google Scholar
[7. Camfield P, Camfield C. When is it safe to discontinue AED treatment? Epilepsia. 2008; 49 (Suppl. 9): 25-28.10.1111/j.1528-1167.2008.01923.x]Search in Google Scholar
[8. Glauser T, Ben-Menachem E, Bourgeoiset B, et al. ILAE Treatment Guidelines: Evidence-based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes. Epilepsia. 2006; 47(7): 1094-1120.10.1111/j.1528-1167.2006.00585.x]Search in Google Scholar
[9. J. A. French, A. M. Kanner, J. Bautista, et al. Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Societ Neurology. 2004; 62: 1252-1260.]Search in Google Scholar
[10. J. A. French, A. M. Kanner, J. Bautista, et al. Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.]Search in Google Scholar
[11. National Institute for Health and Clinical Excellence. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care (update). (Clinical guideline 137.)]Search in Google Scholar
[2012. http://guidance.nice.org.uk/CG137.]Search in Google Scholar
[12. Beydoun A, D'Souza J. Treatment of idiopathic generalized epilepsy - a review of the evidence. Expert Opin Pharmacother. 2012; 13(9): 1283-98.10.1517/14656566.2012.685162]Search in Google Scholar
[13. Bourgeois BF. Chronic management of seizures in the syndrom es of idiopathic generalized epilepsy. Epilepsia. 2003; 44 Suppl 2: 27-32.10.1046/j.1528-1157.44.s.2.1.x]Search in Google Scholar
[14. S. Noachtar, E. Andermann, P. Meyvisch, F. Andermann, W. B. Gough, J. Schiemann-Delgado, Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures Neurology. 2008; 70(8): 607-616.]Search in Google Scholar
[15. Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 16, 2002; 695-714.10.2165/00023210-200216100-00004]Search in Google Scholar
[16. Marson A.G, Al-Kharusi A.M, Alwaidh M, Appleton R, Baker G.A, et al. SANAD Study group, 2007. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet. 369, 1016-1026.10.1016/S0140-6736(07)60461-9]Search in Google Scholar
[17. Gelisse P, Genton P, Kuate C, Pesenti A, Baldy- Moulinier M, Crespel A. Worsening of Seizures by Oxcarbazepine in Juvenile Idiopathic Generalized Epilepsies. Epilepsia. 2004; 45: 1282-1286. 1. 1.10.1111/j.0013-9580.2004.19704.x15461683]Search in Google Scholar
[18. Thomas P, Valton L and Genton P. Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain. 2006; 129, 1281-1292.]Search in Google Scholar
[19. Lige Liu, Thomas Zheng, Margaret J. Morris, Charlott Wallengren, Alison L. Clarke, Christopher A. Reid, et al. The Mechanism of Carbamazepine Aggravation of Absence Seizures. The Journal of Pharmacology and Experimental Therapeutics. 2006; 319: 790-798.10.1124/jpet.106.10496816895979]Search in Google Scholar